Endogenous active efflux of norfloxacin in susceptible Escherichia coli
about
NorM, a putative multidrug efflux protein, of Vibrio parahaemolyticus and its homolog in Escherichia coliNorA functions as a multidrug efflux protein in both cytoplasmic membrane vesicles and reconstituted proteoliposomesResistance emerging after pefloxacin therapy of experimental Enterobacter cloacae peritonitis.Transport of pefloxacin across the bacterial cytoplasmic membrane in quinolone-susceptible Staphylococcus aureusRole of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: resistance to tetracycline, chloramphenicol, and norfloxacinRole of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: active efflux as a contributing factor to beta-lactam resistance.Association between double mutation in gyrA gene of ciprofloxacin-resistant clinical isolates of Escherichia coli and MICsImpact of gyrA and parC mutations on quinolone resistance, doubling time, and supercoiling degree of Escherichia coli.Ineffectiveness of topoisomerase mutations in mediating clinically significant fluoroquinolone resistance in Escherichia coli in the absence of the AcrAB efflux pump.Accumulation of norfloxacin by Bacteroides fragilis.Efflux-mediated resistance to fluoroquinolones in gram-negative bacteriaTrade-offs between drug toxicity and benefit in the multi-antibiotic resistance system underlie optimal growth of E. coliRelationship between quinolone use and emergence of ciprofloxacin-resistant Escherichia coli in bloodstream infectionsMutation in the gyrA gene of quinolone-resistant clinical isolates of Acinetobacter baumanniiDetection of mutations in parC in quinolone-resistant clinical isolates of Escherichia coli.Gyrase mutations in laboratory-selected, fluoroquinolone-resistant mutants of Mycobacterium tuberculosis H37Ra.Contributions of individual mechanisms to fluoroquinolone resistance in 36 Escherichia coli strains isolated from humans and animals.Regulation of chromosomally mediated multiple antibiotic resistance: the mar regulon.Mechanisms of quinolone resistance in Escherichia coli: characterization of nfxB and cfxB, two mutant resistance loci decreasing norfloxacin accumulation.Analysis of acquired ciprofloxacin resistance in a clinical strain of Pseudomonas aeruginosa.Cross-resistance to fluoroquinolones in multiple-antibiotic-resistant (Mar) Escherichia coli selected by tetracycline or chloramphenicol: decreased drug accumulation associated with membrane changes in addition to OmpF reduction.Outer membrane barrier as a mechanism of antimicrobial resistance.Factors influencing the accumulation of ciprofloxacin in Pseudomonas aeruginosa.Norfloxacin binds to human fecal materialActive efflux mechanisms for antimicrobial resistance.Efflux-mediated fluoroquinolone resistance in Staphylococcus aureus.Ciprofloxacin-induced, low-level resistance to structurally unrelated antibiotics in Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureusPenetration of lipophilic agents with multiple protonation sites into bacterial cells: tetracyclines and fluoroquinolones as examples.Characterization of fluoroquinolone-resistant mutants of escherichia coli selected in vitro.Quinolone resistance mediated by norA: physiologic characterization and relationship to flqB, a quinolone resistance locus on the Staphylococcus aureus chromosome.Genetics and regulation of outer membrane protein expression by quinolone resistance loci nfxB, nfxC, and cfxBQuinolone accumulation in Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus.Multiple antibiotic resistance in Pseudomonas aeruginosa: evidence for involvement of an efflux operon.Active efflux of fluoroquinolones in Mycobacterium smegmatis mediated by LfrA, a multidrug efflux pump.Mechanisms of quinolone resistance in a clinical isolate of Escherichia coli highly resistant to fluoroquinolones but susceptible to nalidixic acidEscherichia coli resistant to cephalosporins and quinolones is still susceptible to the cephalosporin-quinolone ester Ro 23-9424Impermeability to quinolones in gram-positive and gram-negative bacteria.Outer membrane permeability and antibiotic resistance.Quinolone antimicrobial agents: adverse effects and bacterial resistance.The 4-quinolone antibiotics: past, present, and future.
P2860
Q24519031-432A3B8F-2D80-4035-8046-0F094EA498E4Q33183378-F01C2A34-F181-437D-82E2-25CBE43CF3BEQ33742745-60FE1570-003E-45CD-ABE0-433390AAE434Q33745800-624A6BDB-88D1-433B-822A-B26D5A46C984Q33756446-231EE535-6393-488F-8378-7E5679955E95Q33756505-B0C738FB-A26C-451E-BBD9-E2748A3A4FC3Q33762110-232F6A41-F1EE-4C9F-A6C3-015FE12CAE97Q33976675-08FB88D4-4F9E-4A4E-B43B-820280AD7A0BQ33978398-F0031344-FDB0-494F-BDEC-58D7F62607E6Q33980437-CB992547-50AB-438F-AB14-DA2D2EAED55CQ34010692-E8A785C0-3515-452D-9E9A-F409553FE718Q34282602-03329C95-F817-49BE-B342-40E3DC623141Q35111896-F6238124-9CAC-436B-80CD-9D13A96AFE8EQ35114895-750DE29C-E8B6-423F-8E76-984F2B20668EQ35122643-932E963F-7F69-4FEC-BD67-D26D2DFEAEACQ35125890-C8A692F3-80B4-4324-AB20-F8190C8E0B96Q35128319-9A351D9C-C7B1-454F-8B8F-3EA6529E7CCBQ35138349-EE1A825C-90F6-4B67-B0BE-25A808AAEA98Q35244676-B9E34026-63D6-4FBB-B729-2BE709A86640Q35248719-0CCA07B1-9909-482C-9E34-0D96D6D2BA10Q35343881-1F849EB8-FCEF-4C0E-B452-896EEBD83587Q35357625-4BCC4D6F-1359-4635-825A-63A3A229E413Q35359592-0CDD59C0-C525-4952-8B47-A21B29A28126Q35566005-D6C355A2-5F97-4BEB-BBD9-827FF7812378Q35701032-6324707E-7418-4E81-ADBF-15ECC96E9334Q35814875-9D7664E8-6207-424F-A004-43A0DE715845Q35816058-232062D2-FD00-47D7-8258-53414AA7C541Q35816625-D25F6DB0-6C03-442F-A850-6BAF3348C692Q35821472-6C249EA5-FB6C-49C8-8EA1-096626405CF2Q35821659-386D30A0-8161-4DC7-B499-16532178D76CQ35836816-F311FD33-39AF-46FE-B4EF-74E503AAA322Q35893473-2092B1DB-DFD9-43B2-BEC5-2B232E041C11Q36123973-518A4D52-81CD-44F6-A7CD-80EC8F5BBB3DQ36574542-3D8BBADD-B4FF-49B7-8395-815BB1011B92Q36753126-13DC9CF7-25A2-4896-BBAD-F20C0CF65A0DQ36753777-37A65415-88DA-41F9-A8D6-8880FFEC5907Q37222568-8BA9BC88-39A4-415F-85E5-59921FBF74B8Q37227443-A346565C-8B0E-4C55-A592-D9F1AD5D3AE6Q38322827-27571687-651A-4E39-A903-AA1D603082D8Q39314610-04D1B28A-3C5C-416E-BBB8-2D85C31EE29A
P2860
Endogenous active efflux of norfloxacin in susceptible Escherichia coli
description
1988 nî lūn-bûn
@nan
1988 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
name
Endogenous active efflux of norfloxacin in susceptible Escherichia coli
@ast
Endogenous active efflux of norfloxacin in susceptible Escherichia coli
@en
type
label
Endogenous active efflux of norfloxacin in susceptible Escherichia coli
@ast
Endogenous active efflux of norfloxacin in susceptible Escherichia coli
@en
prefLabel
Endogenous active efflux of norfloxacin in susceptible Escherichia coli
@ast
Endogenous active efflux of norfloxacin in susceptible Escherichia coli
@en
P2093
P2860
P356
P1476
Endogenous active efflux of norfloxacin in susceptible Escherichia coli
@en
P2093
P2860
P304
P356
10.1128/AAC.32.8.1187
P407
P577
1988-08-01T00:00:00Z